Drug Profile
BBI 11008
Alternative Names: BBI-11008Latest Information Update: 22 Jul 2016
Price :
$50
*
At a glance
- Originator Biousian Biosystems
- Class Analgesics; Peptides; Small molecules
- Mechanism of Action Opioid delta receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammatory pain
Most Recent Events
- 22 Jul 2016 No recent reports on development identified - Preclinical for Inflammatory pain in USA (PO)